Julie A. Gazmararian, MPH, PhD

home / authors / julie-a-gazmararian-mph-phd

Articles

March 1st 2005

Can an Algorithm for Appropriate Prescribing Predict Adverse Drug Events?

Kimberly J. Rask, MD, PhD Kristen J. Wells, MPH Gregg S. Teitel, PharmD Jonathan N. Hawley, BS Calita Richards, PharmD Julie A. Gazmararian, MPH, PhD

July 1st 2001

Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

S. Nicole Fehrenbach, MPP Daniel S. Budnitz, MD, MPH Julie A. Gazmararian, MPH, PhD Harlan M. Krumholz, MD

Latest Updated Articles

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Blood smear AML | image credit: Chansom Pantip - stock.adobe.com

Published: October 20th 2024 | Updated: November 5th 2024

FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions